DE60024593D1 - Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthalten - Google Patents
Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthaltenInfo
- Publication number
- DE60024593D1 DE60024593D1 DE60024593T DE60024593T DE60024593D1 DE 60024593 D1 DE60024593 D1 DE 60024593D1 DE 60024593 T DE60024593 T DE 60024593T DE 60024593 T DE60024593 T DE 60024593T DE 60024593 D1 DE60024593 D1 DE 60024593D1
- Authority
- DE
- Germany
- Prior art keywords
- dietetic
- cosmetic
- cystein
- pharmaceutical composition
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 title abstract 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title abstract 2
- 230000000378 dietary effect Effects 0.000 title abstract 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title 1
- 235000019136 lipoic acid Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960002663 thioctic acid Drugs 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 230000034659 glycolysis Effects 0.000 abstract 1
- 230000004130 lipolysis Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000002438 mitochondrial effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI000460A IT1312377B1 (it) | 1999-03-05 | 1999-03-05 | Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche |
| ITMI990460 | 1999-03-05 | ||
| PCT/EP2000/001637 WO2000053176A1 (en) | 1999-03-05 | 2000-02-28 | Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60024593D1 true DE60024593D1 (de) | 2006-01-12 |
| DE60024593T2 DE60024593T2 (de) | 2006-08-17 |
Family
ID=11382177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60024593T Expired - Lifetime DE60024593T2 (de) | 1999-03-05 | 2000-02-28 | Pharmazeutische, diätetische kosmetische Zusammensetzungen, die Thioctsäure und Cystein enthalten |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1156802B1 (de) |
| AT (1) | ATE311874T1 (de) |
| AU (1) | AU2915900A (de) |
| DE (1) | DE60024593T2 (de) |
| ES (1) | ES2254145T3 (de) |
| IT (1) | IT1312377B1 (de) |
| WO (1) | WO2000053176A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4182183B2 (ja) * | 1999-08-24 | 2008-11-19 | ディーエスエム アイピー アセッツ ビー．ブイ． | 痩身用皮膚化粧料 |
| WO2001066560A2 (en) * | 2000-03-07 | 2001-09-13 | Forbes Medi-Tech Inc. | Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| US7736661B1 (en) * | 2000-03-07 | 2010-06-15 | Avon Products, Inc | Method of treating skin conditions |
| WO2002013813A1 (en) * | 2000-08-11 | 2002-02-21 | The Lawson Health Research Institute | Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| US6423349B1 (en) * | 2000-08-24 | 2002-07-23 | Baxter International, Inc. | Therapeutic nutrient composition for pre and post elective surgery |
| EP1214893A1 (de) * | 2000-12-16 | 2002-06-19 | Aventis Pharma Deutschland GmbH | Zusammensetzungen zur Verbesserung der Gesundheit |
| WO2002047493A2 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Health promoting compositions |
| DE10111053A1 (de) * | 2001-03-06 | 2002-09-12 | Beiersdorf Ag | Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen |
| SE0102380D0 (sv) * | 2001-07-02 | 2001-07-02 | Macronova Ab | Kräm för behandling av åldersförändringar i huden hos människa |
| US7384920B2 (en) | 2001-07-26 | 2008-06-10 | Institute Of Radiation Medicine, Academy Of Military Medical Sciences, Pla | Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases |
| WO2003037343A1 (en) * | 2001-10-30 | 2003-05-08 | Lonza Ag | Composition comprising folic acid and carnitine useful to enhance male fertility |
| EP2060255B1 (de) * | 2001-11-02 | 2013-06-05 | The Regents of the University of California | Zusammensetzungen zur Vorbeugung und Behandlung von Entzündungskrankheiten, Autoimmunerkrankungen und Transplantatabstoßung |
| DE10305661A1 (de) * | 2003-02-12 | 2004-08-26 | Degussa Ag | Darreichungsform zur Kolon-spezifischen Wirkstofffreisetzung |
| ITMI20032528A1 (it) | 2003-12-19 | 2005-06-20 | Francesco Santangelo | Uso di cistina o di cisteina per la prevenzione e il |
| US8017634B2 (en) * | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
| EP1708689A2 (de) | 2003-12-29 | 2006-10-11 | The President and Fellows of Harvard College | Zusammensetzungen zur behandlung oder verhinderung von adipositas und insulin-resistenten erkrankungen |
| US20080305094A1 (en) | 2004-01-28 | 2008-12-11 | Nestec S.A. | Nutritional Composition for Improving Skin Condition and Preventing Skin Diseases |
| BRPI0512189B1 (pt) * | 2004-06-15 | 2018-02-06 | The Boots Company Plc | Hair care compositions and methods |
| DE502006008551D1 (de) * | 2005-02-04 | 2011-02-03 | Peter Heger | Verfahren zur herstellung eines hydroxystilben-haltigen drogenextraktes |
| DE102005005270A1 (de) * | 2005-02-04 | 2006-08-10 | Peter Heger | Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Behandlung leichter bis mittelschwerer Depressionen und Angstzustände |
| WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
| AT503219B1 (de) * | 2006-02-03 | 2008-07-15 | Annerl Brigitte | Kombinationspräparat auf basis von antioxidanzien zur verbesserung der samenqualität |
| NL2000008C2 (nl) * | 2006-02-16 | 2007-08-17 | Apo Pharmaceuticals Internat B | Samenstelling en doseereenheid als voedingssupplement en voor de behandeling van retinis pigmentosa. |
| ITRM20060108A1 (it) | 2006-03-03 | 2007-09-04 | Colella Gino | Composizioni a base di melatonina e sostanze immunostimolanti |
| EP1932542A1 (de) * | 2006-12-15 | 2008-06-18 | TIMA Foundation | Antioxidantzusammensetzung und ihre Verwendung in Diabetes |
| DE102007013145A1 (de) * | 2007-03-15 | 2008-09-18 | Henkel Ag & Co. Kgaa | Wellmittel mit Haarfaserstrukturanten |
| WO2012130609A1 (en) | 2011-04-01 | 2012-10-04 | Iasomai Ab | New combination comprising n-acetyl-l-cysteine and its use |
| JP5777821B2 (ja) | 2011-11-15 | 2015-09-09 | ティーマ ファウンデーション | 細胞傷害作用からの防御のための組成物 |
| RU2495675C1 (ru) * | 2012-06-26 | 2013-10-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет Министерства здравоохранения и социального развития РФ" | Способ лечения угревой болезни |
| WO2016131784A1 (en) * | 2015-02-17 | 2016-08-25 | Ares Trading S.A. | Topical liquid composition comprising melatonin |
| WO2024099702A1 (en) * | 2022-11-11 | 2024-05-16 | Unilever Ip Holdings B.V. | A personal care composition |
| WO2024099690A1 (en) * | 2022-11-11 | 2024-05-16 | Unilever Ip Holdings B.V. | A personal care composition |
| WO2024099689A1 (en) * | 2022-11-11 | 2024-05-16 | Unilever Ip Holdings B.V. | A personal care composition |
| WO2024099688A1 (en) * | 2022-11-11 | 2024-05-16 | Unilever Ip Holdings B.V. | Personal care composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4630M (de) * | 1965-06-09 | 1966-11-28 | ||
| JP2565513B2 (ja) * | 1987-09-25 | 1996-12-18 | 三省製薬株式会社 | メラニン生成抑制外用薬剤 |
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| DE4328871A1 (de) * | 1993-08-27 | 1995-03-02 | Beiersdorf Ag | Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis |
| ATE444760T1 (de) * | 1997-01-13 | 2009-10-15 | Univ Emory | Glutathion zur behandlung von influenzainfektionen |
| WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
| US5904924A (en) * | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
-
1999
- 1999-03-05 IT IT1999MI000460A patent/IT1312377B1/it active
-
2000
- 2000-02-28 EP EP00907644A patent/EP1156802B1/de not_active Expired - Lifetime
- 2000-02-28 AT AT00907644T patent/ATE311874T1/de not_active IP Right Cessation
- 2000-02-28 AU AU29159/00A patent/AU2915900A/en not_active Abandoned
- 2000-02-28 WO PCT/EP2000/001637 patent/WO2000053176A1/en active IP Right Grant
- 2000-02-28 DE DE60024593T patent/DE60024593T2/de not_active Expired - Lifetime
- 2000-02-28 ES ES00907644T patent/ES2254145T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2254145T3 (es) | 2006-06-16 |
| DE60024593T2 (de) | 2006-08-17 |
| WO2000053176A1 (en) | 2000-09-14 |
| EP1156802B1 (de) | 2005-12-07 |
| ATE311874T1 (de) | 2005-12-15 |
| EP1156802A1 (de) | 2001-11-28 |
| AU2915900A (en) | 2000-09-28 |
| IT1312377B1 (it) | 2002-04-15 |
| ITMI990460A1 (it) | 2000-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60024593D1 (de) | Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthalten | |
| TR200100610T2 (tr) | Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim | |
| DE69530389D1 (de) | Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen | |
| DK1331927T3 (da) | Topisk komposition der indeholder mindst et D-vitamin eller en D-vitamin analog og mindst et kosttikosteroid | |
| KR19980700976A (de) | ||
| YU57600A (sh) | Derivarti biciklične hidroksaminske kiseline | |
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| GEP20012578B (en) | (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity | |
| PT1047397E (pt) | Composicoes topicas para aumento da producao de glutationa | |
| AU7263591A (en) | Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors | |
| GEP19991871B (en) | Thiol Derivatives with Metallopeptidase Inhibitory Activity | |
| TR199700858A2 (xx) | Alzheimer hastal���n�n tedavisine y�nelik ispen�iyari bile�imler. | |
| TR200100333T2 (tr) | Bir karnitin ve bir karotenoit içeren antioksidan, antiproliferos bileşim | |
| CY1106168T1 (el) | Συνθεση για την προληψη και/ή θepαπεια αγγειακων ασθενειων που συνισταται απο προπιονυλ l-καρνιτινη και συνενζυμο q10 | |
| DE69819519D1 (de) | Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika | |
| IL106107A (en) | Imidazolyl-substituted cyclohexane derivatives, their preparation and pharmaceutical compositions containing them | |
| DK0749977T3 (da) | Nye 17-hydroxyiminoalkyl- og 17-hydroxyiminomethylalkenylcyclopentanperhydrophenanthrenderivater aktive på det cardiovaskul | |
| DE60112578D1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase | |
| DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
| BR9508521A (pt) | Inibição da biossintese de leucotrienos com derivados de uréia | |
| UA64074C2 (uk) | Кардіопротекторний антиоксидантний засіб "елгацин" | |
| KR970000215A (ko) | 대추추출물을 유효성분으로 하는 치주질환 예방 및 치료제 | |
| MX9204369A (es) | Formulacion de vitaminas, minerales y otros complementos beneficos, de liberacion sostenida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |